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Article focus
  Peripheral blood mononuclear cells 
treated with the quality and quantity cul-
ture method are a potential cell candi-
date for clinical application in cases of 
bone nonunion.
  Peripheral blood mononuclear cells have 
no serious ethical or technical problems 
associated with their use, in contrast to 
human embryonic stem cells, neural 
stem cells, or mesenchymal stem cells.
  Angiogenic conditioning culture of 
PBMNCs enhances the radiological and 
histological repair of bone fractures.
Key messages
  the angiogenic and osteogenic potential 
of PBMNCs could be amplified by ex vivo 
conditioning culture.
  QQMNCs accelerate bone fracture 
healing.
Strengths and limitations
  strengths: this is the first study to dem-
onstrate the potential use of PBMNCs 
cultured with a special medium for frac-
ture healing as a more feasible and prom-
ising cell candidate in the clinical 
setting.
Angiogenic conditioning of peripheral 
blood mononuclear cells promotes 
fracture healing
Objectives
The objective of this study was to investigate the therapeutic effect of peripheral blood 
mononuclear cells (pBMncs) treated with quality and quantity control culture (QQ-culture) 
to expand and fortify angiogenic cells on the acceleration of fracture healing.
Methods
Human pBMncs were cultured for seven days with the QQ-culture method using a serum-
free medium containing five specific cytokines and growth factors. The QQ-cultured 
pBMncs (QQMncs) obtained were counted and characterised by flow cytometry and real-
time polymerase chain reaction (RT-pcR). Angiogenic and osteo-inductive potentials were 
evaluated using tube formation assays and co-culture with mesenchymal stem cells with 
osteo-inductive medium in vitro. In order to evaluate the therapeutic potential of QQMncs, 
cells were transplanted into an immunodeficient rat femur nonunion model. The rats were 
randomised into three groups: control; pBMncs; and QQMncs. The fracture healing was 
evaluated radiographically and histologically.
Results
The total number of pBMncs was decreased after QQ-culture, however, the number of 
cD34+ and cD206+ cells were found to have increased as assessed by flow cytometry 
analysis. In addition, gene expression of angiogenic factors was upregulated in QQMncs. 
In the animal model, the rate of bone union was higher in the QQMnc group than in the 
other groups. Radiographic scores and bone volume were significantly associated with the 
enhancement of angiogenesis in the QQMnc group.
Conclusion
We have demonstrated that QQMncs have superior potential to accelerate fracture healing 
compared with pBMncs. The QQMncs could be a promising option for fracture nonunion.
cite this article: Bone Joint Res 2017;6: 489–498.
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  limitations: We used a small number of animals to 
evaluate fracture healing and we did not compare 
other cell fractions such as mesenchymal stem cells, 
CD34+ cells or bone marrow CD34+ cells.
Introduction
Fractures may fail to heal for a variety of reasons, includ-
ing both mechanical and biological factors. A key 
mechanical factor is stability of the fracture site, while 
reduced osteogenic potential and loss of vascularity are 
important biological factors leading to nonunion.1-3 
standard treatment involves autologous bone grafting, 
but graft harvesting is associated with morbidity while 
graft supply is limited, and grafts have unpredictable 
reparative potential.4
the cell therapy approach has been adopted to aug-
ment the effectiveness of biological factors. Mesenchymal 
stem cells (MsCs), bone marrow mononuclear cells 
(BMMNCs) and CD34+ cells have all been proposed as 
cell candidates.5-7 In particular, CD34+ cells (the cell frac-
tion containing endothelial progenitor cells (EPCs)) are 
used for cell-based angiogenic therapy, and their thera-
peutic effect on fracture healing was demonstrated in 
preclinical and clinical studies.7,8 thus, CD34+ cells have 
been shown to have a potential for acceleration of bone 
healing by improving angiogenesis. However, CD34+ 
cell therapy has limitations. First, the number of these 
cells is limited, comprising < 0.01% of the cells in periph-
eral blood and 0.1% in bone marrow.9 second, ageing or 
disease attenuates the therapeutic potential of the cells.10 
third, to obtain this cell fraction, invasive procedures are 
required such as apheresis and the administration of 
granulocyte colony-stimulating factor (g-CsF).8 to over-
come these problems, Masuda et al10 developed a serum-
free culture system with added cytokines and growth 
factors to increase the angiogenic cell fraction using stem 
cell factor (sCF), thrombopoietin (tPo), Flt-3 ligand, 
interleukin-6 (Il-6), and vascular endothelial growth fac-
tor (vEgF). With the use of this culture method, CD34+ 
cells can be expanded while maintaining their CD34 pos-
itivity and increasing their angiogenic potential. Based on 
these effects, this approach was named ‘quality and 
quantity culture’ (QQ-culture).11 to minimise the inva-
siveness and cost of the cell isolation procedure, this 
QQ-culture method was applied to PBMNCs. A preclini-
cal study demonstrated that this approach upregulated 
the cells’ angiogenic and anti-inflammatory potentials, 
and showed that cultured cells had greater therapeutic 
effect in a mouse hind limb ischaemia model.12 Based on 
these preliminary results, we hypothesised that human 
PBMNCs treated by the QQ-culture method (QQMNCs) 
could be favourable candidates for fracture healing.
In this study, we aimed to evaluate the angiogenic and 
osteogenic potential of QQMNCs, and to investigate 
whether QQMNCs accelerate fracture healing in a femo-
ral fracture nonunion model in immunodeficient rats.
Materials and Methods
this study was approved by the institutional animal com-
mittee of Hiroshima university (A14-52). All animals were 
treated according to the guidelines stipulated by the 
Institutional Animal Care and use Committee.
Quality and quantity culture. samples of human periph-
eral blood (20 ml) were collected from healthy volunteers, 
and PBMNCs were isolated by density gradient centrifu-
gation using lymphocyte separation solution (lsM) (d = 
1.077, Histopaque-1077 sterile-filtered; sigma-Aldrich, st 
louis, Missouri), as previously reported.8 Informed con-
sent was obtained from all volunteers. Isolated PBMNCs 
were treated by the QQ-culture method for seven days 
without any change of medium at a density of 2 × 106 
cells/2 ml/well in six-well culture plates (BD Biosciences, 
#353846, Primaria, BD Falcon, san Jose, California). the 
complete QQ-culture medium was prepared using serum-
free medium (stem line; sigma-Aldrich) supplemented 
with human stem cell factor (sCF) (#130-096-692, con-
centration 100 ng/ml; Miltenyi Biotec, Bergisch gladbach, 
germany), human thrombopoietin (tPo) (#130-094-011, 
concentration 20 ng/Ml; Miltenyi Biotec), human Fms-
related tyrosin kinase (Flt)-3 ligand (#130-096-474, con-
centration 100 ng/Ml; Miltenyi Biotec), human vascular 
endothelial growth factor (vEgF) (#100-20, concentration 
50 ng/ml; Peprotech EC ltd, london, united Kingdom), 
and human interleukin (Il)-6 (#130-095-365, concentra-
tion 20 ng/ml; Miltenyi Biotec). Cell density in QQ culture 
corresponded to approximately 1 × 106 PBMNCs in 1 ml 
as previously reported (supplementary Fig. a).12,13 After 
culture, QQMNCs were counted and used for further 
analysis as described below.
Cell characterisation by flow cytometry. to characterise 
PBMNCs and QQMNCs (n = 6 per group), fluorescence-
activated cell sorting (FACs) analysis was performed 
using a BD lsRFortessa Cell Analyzer (BD Biosciences) and 
CellQuest software (BD Biosciences) after staining with 
mouse anti-human monoclonal antibodies against the fol-
lowing surface markers: Cluster of Differentiation (CD)34-
Brilliant violet (Bv) 421 (clone 581; BD Biosciences); 
vascular Endothelial growth Factor Receptor(vEgFR)2-
Phycoerythrin(PE) (clone 7D4-6; Biolegend, san 
Diego, California); Cluster of Differentiation (CD206)-
fluorescein(FItC) (clone 15-2; Biolegend); and C-C che-
mokine receptor type 2 (CCR2)- Brilliant violet (Bv)605 
(clone K036C2; Biolegend). Dead cells were excluded on 
the basis of 7-Amino-Actinomycin D (7-AAD) staining (BD 
Biosciences). Cells were stained with monoclonal anti-
bodies for 20 minutes at 4°C following Fc receptors (FcR) 
blocking, washed twice using Hank’s buffered salt solu-
tion containing 2% fetal bovine serum (FBs), and then 
analysed. Relevant isotype controls (Immunoglobulin 
g(Igg)1-Bv421 isotype control (BD Biosciences), Igg1-PE 
(BD Biosciences), Igg1-FItC (BD Biosciences), and 
Igg2a-Bv605 (Biolegend)) were also used. In all samples, 
20 000 events were acquired.
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Cell characterisation of quality and quantity control-cultured mononuclear cells (QQMNCs). (a) total cell counts of peripheral blood mononuclear cells (PBMNCs) 
and QQMNCs and their images: 2 × 106 cells/2 ml/well were cultured in Quality and Quantity(QQ) culture using five wells in a six well-plate. After culture, QQMNCs 
were counted. the graph shows total counts of PBMNCs and QQMNCs in five wells. this graphs show that total cell number decreases after culture (**p < 0.01, n = 
12). Phase contrast image of PBMNCs and QQMNCs (×40 magnification); b) gene expression of angiogenic markers relative to glyceraldehyde 3-phosphate dehydro-
genase: quantitative real-time polymerase chain reaction (qRt-PCR) assay of PBMNCs and QQMNCs. Each value indicates a mean sd standard deviation (*p < 0.05, 
**p < 0.01; n = 6 volunteers). the expression of both vascular endothelial growth factor (vEgF) and angiopoietin (Ang) 2 were significantly greater in QQMNCs than 
in PBMNCs; c) enhanced in vitro tube formation by human umbilical vein endothelial cells(HuvECs) when co-cultured with QQMNCs. Representative images of each 
group are shown (×40 magnification). the total length of tube formation was calculated by ImageJ software version 1.48 (National Institutes of Health, Bethesda, 
Maryland). the overall length in the QQMNC group was significantly longer than in other groups (**p < 0.01).
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Cell characterisation by quantitative real-time poly-
merase chain reaction. using tRIzol (Invitrogen, thermo 
Fisher scientific, Waltham, Massachusetts), total RNA 
was extracted from PBMNCs or QQMNCs (n = 6 per 
group). Complementary DNA (cDNA) was synthesised 
using 10 ng total RNA with the superscript vIlo cDNA 
synthesis Kit (Invitrogen). A real-time PCR assay was per-
formed using taqMan gene Expression Assay (Applied 
Biosystems, Foster City, California). Relative expression 
was calculated using the ΔΔCt values and results are 
expressed as 2-ΔΔCt. the value of each control sample was 
set at one and was used to calculate the fold difference in 
each target gene. All primers and probes used are listed 
in table I.
Tube formation assay. PBMNCs and QQMNCs were 
evaluated by tube formation assay by co-culturing with 
human umbilical vein endothelial cells (HuvECs) on 
ECMatrix gel (Merck-Millipore, Darmstadt, germany) to 
confirm their angiogenic potential. to solidify the matrix 
solution, 150 µl was incubated at 37°C for one hour 
in a 96-well plate. then 1 × 103 cells from each group 
(PBMNCs, QQMNCs) were mixed with 1.5 × 104 HuvECs 
in 50 µl of Endothelial Basal Medium -2 (EBM-2) com-
plete medium containing 2% FBs, seeded onto the sur-
face of the polymerised ECMatrix and co-cultured. As a 
control, HuvECs were cultured alone. After incubation 
for 12 hours, photomicrographs of each well were taken 
under a light microscope (IX71N-22Fl/PH; olympus, 
tokyo, Japan), and then the length of tube formation was 
calculated using ImageJ software version 1.48 (National 
Institutes of Health, Bethesda, Maryland) (n = 16 in each 
group four donors, repeated four times ).
Osteogenic induction of MSCs in vitro. Commercially avail-
able primary human bone marrow MsCs (BMMsCs) 
from healthy donors (lonza ltd, Basel, switzerland) were 
cultured and expanded in a specific medium, mesenchy-
mal stem cell growth medium (MsCgM Bulletkit; lonza 
ltd). MsCs at passage four were seeded into 12-well 
plates with an initial seeding density of 10 000 cells/cm2 
and preconditioned in osteogenic induction medium 
(stemPro osteogenesis Differentiation Kit; thermo Fisher 
scientific) at 37°C for one day. After preconditioning, the 
MsCs were co-cultured with PBMNCs or QQMNCs (1 × 
105 cells, n = 12 in each group; three donors, repeated 
four times) using cell culture inserts (Falcon Cell Culture 
Inserts: For use With 12-Well Plates#353180 ) for seven 
days. As a control, MsCs alone were cultured in osteo-
genic induction medium. total RNA was extracted from 
the MsCs at days 3 and 7 of co-culture using tRIzol, and 
cDNA was synthesised. A real-time PCR assay was per-
formed in the same manner as described above. All prim-
ers and probes used in this analysis are listed in table I. 
For evaluation of calcium deposition, the MsCs were 
stained with Alizarin Red s (CAs No. 130-22-3; sigma-
Aldrich) at day 14 of co-culture, and the stained area was 
measured using ImageJ software.
Animal study
Animals and surgical procedure. Male athymic nude rats 
(F344/NJcl-rnu/rnu, nine to ten weeks old, (ClEA Japan, 
Inc, tokyo, Japan) were used to evaluate the therapeu-
tic potential of QQMNCs in vivo. All surgical procedures 
were performed under normal sterile conditions. the 
rats were anaesthetised using ketamine (100 mg/kg) and 
xylazine (12 mg/kg) by intraperitoneal administration. A 
transverse femoral fracture was created in the right femur 
of each rat and nonunion was induced by cauterising the 
periosteum to a distance of 2 mm on each side of the 
fracture, as previously described.14,15 In order to avoid 
significant displacement of the fracture and achieve well-
aligned stability, a 1.2 mm diameter Kirschner wire was 
inserted from the trochlear groove into the femoral canal 
in a retrograde manner. Finally, the wound was tightly 
closed in layers. Rats were then randomised to three 
groups: control; PBMNC; and QQMNC. In the PBMNC 
and QQMNC groups, 2 × 105 cells were injected into the 
site immediately after surgery while the control group 
received phosphate-buffered saline (PBs) alone.
evaluation of fracture healing. Rats were anaesthetised 
before imaging. serial radiographs were taken at zero, 
two, four, six and eight weeks after surgery, and fracture 
healing was evaluated by Qui’s radiographic scoring sys-
tem (n = 8 in each group and at each time point).16
For micro-Ct imaging (µCt), rats were killed at two, 
four and eight weeks, and the right femurs were har-
vested. the femurs were fixed in 4% paraformaldehyde 
(Wako Pure Chemical Industries ltd, osaka, Japan) at 4°C 
for 24 hours, wires were removed, and µCt images were 
acquired (skyscan 1176; Bruker, Kontich, Belgium). the 
imaging settings were as follows: acceleration voltage: 40 
kv; beam current: 800  µA, no filter; resolution: 18  μm; 
and rotation: 360° in 1° steps. Acquired images were 
reconstructed using the manufacturer’s software (NRecon 
version 1.6.4.1; skyscan), and total callus volume (tv), 
Table I. list of primers used in real-time polymerase chain reaction
Type  
Human probes Angiogenic vEgFA Hs 00900055_m1
 angiopoetin1 Hs 00375822_m1
 angiopoetin2 Hs00169867_m1
 osteogenic RuNX2 Hs 00231692_m1
 type1 collagen Hs 00164004_m1
 osteocalcin Hs 01587814_g1
 Internal control gAPDH Hs 02758991_g1
Rat probes Angiogenic vEgF Rn 0511601_m1
 FgF2 Rn 00570809_m1
 osteogenic RuNX2 Rn 01512298_m1
 type1 collagen Rn 01463848_m1
 osteocalcin Rn 00566386_g1
 Internal control gAPDH Rn 01749022_g1
vEgFA, vascular endothelial growth factor A; RuNX2, Runt-related
transcription factor 2; gAPDH, glyceraldehyde 3-phosphate dehydrogenase; 
FgF2, fibroblast growth factor 2
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mineralised bone volume (Bv), and bone volume fraction 
(Bv/tv) were analysed on either side, 2 mm away from 
the fracture site using a Ct Analyzer, version 1.11.8.0 
(skyscan) (two weeks: n = 6 per group; four weeks: n = 6 
per group; and eight weeks: n = 8 per group).
histological evaluation. After µCt scanning, the right 
femurs were decalciﬁed with 0.5 M ethylenediamine-
tetraacetic acid (EDtA) solution for three weeks. the 
samples were embedded in parafﬁn, and cut into 5 µm 
thick sections through the site of the fracture. the sec-
tions were stained with toluidine blue and the process of 
endochondral ossification was evaluated at two, four and 
eight weeks after surgery. the degree of fracture heal-
ing was evaluated using the five-point scale (grades 0 to 
4) proposed by Allen, Wase and Bear.17 the assessment 
was blinded. In addition, the sections at two weeks after 
surgery were stained for smooth muscle actin to assess 
angiogenesis. Researchers blinded to the identity of each 
group counted the number of capillary structures in 
five random areas around the fracture sites using a light 
microscope (×200 magnification). the capillary density 
was then calculated as the number of vessels/mm2 as 
previously described.18
Gene expression analysis (around the fracture site). From 
the two-week old rat model, the tissue around the frac-
ture site was harvested after death, and RNA was iso-
lated (n = 6 per group). Real-time PCR was performed 
to evaluate fracture healing-related gene levels as 
described above. All primers and probes used are listed 
in table I.
Statistical analysis. All values are expressed as means and 
standard error. student’s t-test (for two groups), analy-
sis of variance (ANovA) and tukey’s post hoc test (more 
than two groups) were used. Probability (p) values of less 
than 0.05 were considered statistically significant.
Results
Cell number and population transition after QQ cul-
ture. the fold decrease of QQMNCs to PBMNCs per well 
in all subjects was an average of 0.358-fold (Fig. 1a).
Based on fluorescence-activated cell sorting, QQMNCs 
exhibited enrichment of CD34+ and CD206+ cells 
compared with PBMNCs (10.01-fold in CD34+ cells, 
26.04-fold in CD206+ cells, table II). In contrast, the 
population of vascular Endothelial growth Factor 
Receptor(vEgFR)-2+ and C-C chemokine receptor type 2 
(CCR2+ cells) was significantly lower in QQMNCs than 
in PBMNCs (0.33-fold in vEgFR-2+ cells, 0.50-fold in 
CCR2+ cells) (supplementary Fig. b).
enhanced angiogenic gene expression in QQMNCs. 
Expression of genes encoding angiogenic factors, includ-
ing vEgFA and angiopoietin-2 (Ang2), was significantly 
upregulated in QQMNCs compared with PBMNCs (3.58-
fold for vEgF-A, 25.6-fold for Ang2). In contrast, there 
was no significant difference in Ang1 expression between 
QQMNCs and PBMNCs (Fig. 1b).
QQMNCs promote tube formation in vitro. In an in vitro 
tube formation assay involving co-culture with HuvECs, 
QQMNCs showed greater angiogenic potential at 12 
hours. total tube length in the QQMNC group was sig-
nificantly longer than in the PBMNC and control groups 
(tube length 44.5 mm, sd 3.4 for HuvECs and QQMNCs; 
39.4 mm, sd 4.7 for HuvECs and PBMNCs; and 38.5 mm, 
sd 5.1 for HuvECs alone (Fig. 1c).
QQMNCs enhance osteo-induction of MSCs in vitro. At day 
3 of co-culture, real-time PCR revealed that the expres-
sions of RuNX2 and type 1 collagen were significantly 
upregulated in the QQMNC group compared with the 
PBMNC and control groups. At day 7, the expression 
of osteocalcin was significantly higher in the QQMNC 
group compared with the PBMNC and control groups 
(Fig. 2a). Alizarin Red staining of co-cultures at day 14 
showed a significantly larger stained area in the QQMNC 
group compared with the control group. However, there 
was no significant difference between the PBMNC and 
QQMNC groups (Fig. 2b).
QQMNCs accelerate fracture healing. Fracture healing 
was evaluated by radiographic, µCt, and histological 
examinations. Rats which received QQMNCs demon-
strated the highest rate of fracture healing, with bridging 
callus formation observed radiographically (50% (3/6) at 
four weeks, 62.5% (5/8) at eight weeks). In the group of 
rats receiving PBMNCs, only one achieved radiographic 
fracture healing at eight weeks (12.5% (1/8)), while none 
of the rats in the control group achieved radiographic 
fracture healing (Fig. 3a, table III). Qi’s radiographic frac-
ture healing score was significantly higher in the QQMNC 
group than in the other groups at eight weeks (QQMNCs: 
5.88, sd 0.64; PBMNCs: 3.0, sd 0.33; control: 2.63, 
sd 0.182) (Fig. 3a). the µCt analysis confirmed the same 
rates of fracture healing at eight weeks (QQMNCs: 62.5%; 
PBMNCs: 12.5%; control: 0%) (Fig. 3b). In the quantita-
tive evaluation of bone formation, the value of Bv/tv was 
significantly higher in the QQMNC group compared with 
the other groups at eight weeks (QQMNCs: 48.81%, sd 
0.90%; PBMNCs: 37.04%, sd 9.13%; control: 34.61%, sd 
6.21%) (Fig. 3b).
Table II. Percentage of positives among the cell population in 20 000 cells 
of PBMNCs and QQMNCs
PBMNCs % QQMNCs % p-value
CD34 1.20 (se) 0.24 12.1 (sd) 4.04 < 0.05
vEgFR-2 15.0 (se) 1.86 5.02 (sd) 1.01 < 0.01
CD206 0.434 (se) 0.065 11.3 (sd) 3.93 < 0.05
CCR2 25.9 (se) 2.71 12.9 (sd) 4.10 < 0.01
% in PBMNCs and % in QQMNCs indicate the % positivity of each cell popu-
lation in a sample of 20 000 PBMNCs or QQMNCs, data compared with the 
value of PBMNCs n = 6 volunteers
CD34: Cluster of Differentiation 34, vEgFR2: vascular Endothelial growth 
Factor Receptor 2. CD206: Cluster of Differentiation 206, CCR2: C-C chemo-
kine receptor type 2 (all p-values student’s t-test)
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Histological evaluation demonstrated that nonunion 
sites in the PBMNC and QQMNC groups showed 
enhanced endochondral ossification consisting of 
numerous chondrocytes and newly formed trabecular 
bone at two and four weeks after surgery. In five rats of 
the QQMNC group and one in the PBMNC group, 
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Fig. 2b
Real-time polymerase chain reaction (Rt-PCR) assay of osteogenic induction of mesenchymal stem cells (MsCs) co-cultured with peripheral blood mononuclear cells 
(PBMNCs) or quality and quantity control-cultured mononuclear cells (QQMNCs): a) the graphs show the relative gene expression levels of osteogenic factors (type 
1 collagen, RuNX2, and osteocalcin) (**p < 0.01, tukey’s post hoc test). Expression of osteocalcin was undetectable at day 3. the expression levels were compared 
between the QQMNC group and the control and PBMNC groups. Each graph column represents a mean standard deviation (sD); n = 12 per group; b) quantifica-
tion of Alizarin red s staining: MsCs were stained with alizarin red at day 14 of co-culture. Microscopic image of each well of 12-well plate (upper panel: × 40 mag-
nification in 12 wells and lower panel: × 200 magnification) showed enhanced alizarin red staining of MsCs in co-culture with QQMNCs compared with control.
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bridging callus formation was observed at eight weeks. 
the histological score of fracture healing was significantly 
greater in the QQMNC group than in the other groups at 
eight weeks (QQMNCs: 3.50, sd 0.75; PBMNCs: 2.12, sd 
0.99; control: 1.87, sd 0.83) (Fig. 4a).
QQMNCs enhance angiogenesis and osteogenesis in vivo. 
Capillary density was significantly greater in the QQMNC 
group than in the PBMNC and control groups in the tissue 
harvested at two weeks after transplantation (QQMNCs: 
21.67 vessels/mm2, sd 4.96; PBMNCs: 10.95 vessels/
mm2, sd 2.56; control: 10.62 vessels/mm2, sd 3.02) (Fig. 
4b). In addition, in the QQMNC group, several bone 
healing-related genes were significantly upregulated 
(Fig. 5). there were no significant differences in expres-
sion of type 1 collagen and osteocalcin among the three 
groups (Fig. 5).
Discussion
transplantation of CD34+ cells has been shown to pro-
mote fracture healing in a nonunion model.17-19 However, 
difficult and costly isolation procedures are critical draw-
backs to their clinical application as they require granulo-
cyte-colony stimulating factor (gCsF) administration, 
apheresis, and magnetic cell sorting.18,20-22 on the other 
hand, PBMNCs constitute a very accessible cell source 
which can be obtained less invasively at a lower cost com-
pared with CD34+ cells and BMMNCs. Masuda et al cul-
tured PBMNCs in serum-free medium with cytokines and 
growth factors in an effort to fortify the cells’ angiogenic 
potential10,12,23 and generated QQMNCs. our results con-
firm that cultured PBMNCs have superior potential to 
accelerate fracture healing compared with freshly isolated 
PBMNCs in a nude rat model of fracture nonunion.
the presence of circulating Endothelial progenitor cell 
(EPC)s in adult human peripheral blood was first reported 
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Fig. 3b
Evaluation of bone union by radiography and µCt: a) representative radiographs of each group at 0, two, four, six, and eight weeks post-operatively and the 
radiographic scores by Qui in each group at 0, four, and eight weeks. the score in the quality and quantity control-cultured mononuclear cell (QQMNC) group 
was significantly higher than in the other groups (*p < 0.05, ** p < 0.01, tukey’s post hoc test; n = 8); b) representative µCt images from each group at four 
and eight weeks post-operatively. the union rates reflected the radiographic images. Mineralised callus volume (Bv)/total callus volume (tv) (%) was calculated 
using µCt. tv is shown as the red area in the left picture. Bv is shown as the pink area in the right picture. the Bv/tv ratio was calculated from the fracture site 
to 2 mm in each case. Bv/tv in the QQMNC group was significantly higher compared with in the peripheral blood mononuclear cells (PBMNC) and control 
groups. the graph represents the mean sd standard deviation (*p < 0.05, **p < 0.01, tukey’s post hoc test; n = 6).
Table III. Bone union rate in a nonunion model
2 wks 4 wks 6 wks 8 wks
Control (n, %) 0/8, 0 0/8, 0 0/8, 0 0/8, 0
PBMNCs 0/8, 0 1/8, 12.5 1/8, 12.5 1/8, 12.5
QQMNCs 0/8, 0 4/8, 50 4/8, 50 5/8, 62.5
PBMNCs, peripheral blood mononuclear cells; QQMNCs, quality and quan-
tity control-cultured mononuclear cells
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in 1997 by Asahara et al.24 these cells can be obtained as 
CD34+ cells from adult bone marrow.24-26 Adult EPCs are 
mobilised from the bone marrow into peripheral blood 
under tissue ischaemia, where they integrate into ischae-
mic lesions, differentiate into mature endothelial cells, 
and contribute to neovascularisation.24,25,27 Masuda et al12 
previously demonstrated that QQMNCs cultured from 
PBMNCs also contributed to neovascularisation, contrib-
uting extensively to therapeutic effects on vascular regen-
eration and tissue repair. When we investigated 
angiogenic vessel formation by tube formation assay and 
angiogenic gene expression by Rt-PCR in vitro, we found 
the same result. Furthermore, we showed that QQMNCs 
promoted the osteogenic induction of MsCs in co-cul-
ture experiments. In addition to angiogenesis, CD34+ 
cells can also differentiate into osteoblasts in vitro without 
losing their expression of haematopoietic stem cell 
 markers.7,28,29 these findings suggest that CD34+ cells, 
which form part of the cell fraction of QQMNCs, may also 
differentiate into osteogenic cells themselves.
Flow cytometry showed that QQMNCs were enriched 
in CD206+ and impoverished in CCR2+ cells. We specu-
lated that the QQMNC fraction might contain fewer M1 
macrophages and more M2 macrophages than PBMNCs. 
schlundt et  al30 demonstrated that M2 macrophages, 
which express the cell surface antigen CD206, enhance 
bone fracture healing. these results support the hypoth-
esis that the enrichment of M2 macrophages in QQMNCs 
may play a key role in accelerating bone healing.
Many researchers have reported studies on cell ther-
apy for bone fracture healing in the clinical setting. 
Above all, good results have been reported concerning 
transplantation of CD34+ cells as EPCs, and a phase I/II 
clinical trial of autologous CD34+ cell transplantation 
in patients with tibial or femoral nonunion was per-
formed.8,21,22 Fukui et  al19 reported observation of 
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Fig. 4b
Histological evaluation of bone healing after cell transplantation: a) representative histological image (× 40 magnification) of each group stained with toluidine 
blue at two, four, and eight weeks post-operatively (bc, bridging callus; cb, cortical bone; ca cartilage; ft, fibrous tissue; tb trabecular bone). the nonunion 
sites of the peripheral blood mononuclear cell (PBMNC) group and the quality and quantity control-cultured mononuclear cell (QQMNC) group demonstrated 
enhanced endochondral ossification consisting of numerous chondrocytes and newly-formed trabecular bone. the degree of bone healing evaluated by 
Allen’s scoring scale was significantly higher in the QQMNC group than in the other groups at eight weeks post-operatively. the graph represents the mean sd 
standard deviation (*p < 0.05, **p < 0.01;, tukey’s post hoc test n = 6 at two, and four weeks, n = 8 at eight weeks); b) immunohistochemical evaluation of 
neovascularisation by α smooth muscle actin staining at two weeks post-operatively: representative images of each group are shown (top images; ×40 mag-
nification, bottom images; ×200 magnification). the density of capillaries was calculated and can be seen in the graph. the density was significantly higher in 
the QQMNC group than in the control or PBMNC groups. Each column represents the mean sd standard deviation (**p < 0.01, tukey’s post hoc test; n = 6) 
(PBs, phosphate-buffered saline).
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bridging callus formation and complete union in 90% 
of fracture nonunion models of nude rats at weeks 8 
and 12 in the CD34+ group when treated with atelo-
collagen gel. our results showed 62.5% bridging callus 
formation in nonunion models at eight weeks in the 
QQMNC group. these results may indicate that the 
therapeutic effect of QQMNCs is less than that of 
CD34+ cells but may reflect differences in the delivery 
methods: local injection of a cell suspension versus a 3D 
carrier. Fukui et al19 also concluded that the transplan-
tation of PBMNCs contributes to bone repair in nonun-
ion models but is less effective than the transplantation 
of CD34+ cells. In the current study, using our method, 
we demonstrated that the therapeutic effect of PBMNCs 
could be fortified. QQMNCs can be prepared easily and 
at a lower cost than CD34+ cells, rendering them more 
feasible for application in the clinical setting than 
CD34+ cells.
this study has some limitations. First, our nonunion 
models are different from the clinical condition of frac-
ture nonunion. However, we created the model 
following previous reports14,15 to evaluate whether 
QQMNCs promote fracture healing. second, we specu-
lated concerning the role of M2 macrophages, however, 
we did not show direct evidence of the influence of 
QQMNC transplantation on these cells. the issue of 
whether QQMNCs include more M2 macrophages and 
how the macrophages affect fracture healing will need to 
be investigated in the future. Finally, the safety of QQMNCs 
cannot be confirmed, as adverse effects of QQMNCs were 
not addressed. In our conditioning culture of PBMNCs, 
high concentrations of five cytokines and growth factors 
are used. therefore, a careful safety study of these cells for 
future clinical application will be necessary.
In conclusion, we have shown that QQMNCs present 
unique cell fractions with anti-inflammatory phenotype 
and have more angiogenic and osteogenic potentials 
than PBMNCs in vitro. Also, we have demonstrated that 
transplantation of QQMNCs is more effective than PBs or 
PBMNCs in accelerating bone fracture healing in a frac-
ture nonunion model of nude rats. the QQMNCs can be 
prepared easily at a low cost and therefore could be a 
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Fig. 5
quantitative real-time polymerase chain reaction (qRtPCR) of callus around the fracture site at two weeks after implantation. the relative gene expression level 
relating to angiogenic factors (vascular endothelial growth factor (vEgF), fibroblast growth factor 2 (FgF2)). the expression of vEgF was significantly greater in 
the quality and quantity control-cultured mononuclear cell (QQMNC) group than in the control group and the expression of FgF2 was significantly higher in 
the QQMNC group than in the peripheral blood mononuclear cell (PBMNC) and control groups. the relative gene expression levels of osteogenic factors (type 
1 collagen, RuNX2, osteocalcin) are shown in the second row of graphs. the expression of RuNX2 was significantly greater in both experimental groups than in 
the control group (*p < 0.05, **p < 0.01, tukey’s post hoc test; n = 6 per group). Each graph column represents a mean sd standard deviation.
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promising option for the treatment of nonunion fractures 
in the future.
Supplementary material
the QQ culture method of acquiring PBMNCs from 
peripheral blood, the method of CC culture, as well 
as graphs showing PBMNCs and QQMNCs in flow 
cytometry and positive cell population in 20,000 events 
in PBMNCs and QQMNCs are available alongside this 
article at www.bjr.boneandjoint.org.uk
References
 1. Colnot CI, Helms JA. A molecular analysis of matrix remodeling and angiogenesis 
during long bone development. Mech Dev 2001;100:245-250.
 2. Marsh D. Concepts of fracture union, delayed union, and nonunion. Clin Orthop Relat 
Res 1998;355(Suppl):S22-S30.
 3. Heiple KG, Herndon CH. The pathologic physiology of nonunion. Clin Orthop Relat 
Res 1965;43:11-21.
 4. Morshed S, Bhandari M. Clinical trial design in fracture-healing research: meeting 
the challenge. J Bone Joint Surg [Am] 2008;90-A(Suppl 1):55-61.
 5. Licheng Z, Lihai Z, Meng X, Qi Y, Peifu T. Autologous uncultured bone marrow-
derived mononuclear cells and modified cannulated screw in repair of femoral neck 
fracture. J Orthop Res 2013;31:1302-1307.
 6. Bruder SP, Kurth AA, Shea M, et al. Bone regeneration by implantation of purified, 
culture-expanded human mesenchymal stem cells. J Orthop Res 1998;16:155-162.
 7. Matsumoto T, Kawamoto A, Kuroda R, et  al. Therapeutic potential of 
vasculogenesis and osteogenesis promoted by peripheral blood CD34-positive cells 
for functional bone healing. Am J Pathol 2006;169:1440-1457.
 8. Kuroda R, Matsumoto T, Niikura T, et  al. Local transplantation of granulocyte 
colony stimulating factor-mobilized CD34+ cells for patients with femoral and tibial 
nonunion: pilot clinical trial. Stem Cells Transl Med 2014;3:128-134.
 9. Masuda H, Alev C, Akimaru H, et al. Methodological development of a clonogenic 
assay to determine endothelial progenitor cell potential. Circ Res 2011;109:20-37.
 10. Masuda H, Iwasaki H, Kawamoto A, et al. Development of serum-free quality and 
quantity control culture of colony-forming endothelial progenitor cell for vasculogenesis. 
Stem Cells Transl Med 2012;1:160-171.
 11. Tanaka R, Vaynrub M, Masuda H, et al. Quality-control culture system restores 
diabetic endothelial progenitor cell vasculogenesis and accelerates wound closure. 
Diabetes 2013;62:3207-3217.
 12. Masuda H, Tanaka R, Fujimura S, et al. Vasculogenic conditioning of peripheral 
blood mononuclear cells promotes endothelial progenitor cell expansion and 
phenotype transition of anti-inflammatory macrophage and T lymphocyte to cells with 
regenerative potential. J Am Heart Assoc 2014;3:e000743.
 13. Kalka C, Masuda H, Takahashi T, et  al. Transplantation of ex vivo expanded 
endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U 
S A 2000;97:3422-3427.
 14. Kokubu T, Hak DJ, Hazelwood SJ, Reddi AH. Development of an atrophic 
nonunion model and comparison to a closed healing fracture in rat femur. J Orthop 
Res 2003;21:503-510.
 15. Kodama A, Kamei N, Kamei G, et  al. In vivo bioluminescence imaging of 
transplanted bone marrow mesenchymal stromal cells using a magnetic delivery 
system in a rat fracture model. J Bone Joint Surg [Br] 2012;94-B:998-1006.
 16. Qi Y, Zhao T, Yan W, et al. Mesenchymal stem cell sheet transplantation combined 
with locally released simvastatin enhances bone formation in a rat tibia osteotomy 
model. Cytotherapy 2013;15:44-56.
 17. Allen HL, Wase A, Bear WT. Indomethacin and aspirin: effect of nonsteroidal 
anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand 
1980;51:595-600.
 18. Yasuhara S, Yasunaga Y, Hisatome T, et al. Efficacy of bone marrow mononuclear 
cells to promote bone regeneration compared with isolated CD34+ cells from the 
same volume of aspirate. Artif Organs 2010;34:594-599.
 19. Fukui T, Mifune Y, Matsumoto T, et al. Superior Potential of CD34-Positive Cells 
Compared to Total Mononuclear Cells for Healing of Nonunion Following Bone 
Fracture. Cell Transplant 2015;24:1379-1393.
 20. Kawakami Y, Ii M, Alev C, et al. Local transplantation of ex vivo expanded bone 
marrow-derived CD34-positive cells accelerates fracture healing. Cell Transplant 
2012;21:2689-2709.
 21. Kuroda R, Matsumoto T, Kawakami Y, et al. Clinical impact of circulating CD34-
positive cells on bone regeneration and healing. Tissue Eng Part B Rev 2014;20: 
190-199.
 22. Kuroda R, Matsumoto T, Miwa M, et al. Local transplantation of G-CSF-mobilized 
CD34(+) cells in a patient with tibial nonunion: a case report. Cell Transplant 
2011;20:1491-1496.
 23. Alaiti MA, Ishikawa M, Masuda H, et al. Up-regulation of miR-210 by vascular 
endothelial growth factor in ex vivo expanded CD34+ cells enhances cell-mediated 
angiogenesis. J Cell Mol Med 2012;16:2413-2421.
 24. Asahara T, Murohara T, Sullivan A, et  al. Isolation of putative progenitor 
endothelial cells for angiogenesis. Science 1997;275:964-967.
 25. Asahara T, Masuda H, Takahashi T, et  al. Bone marrow origin of endothelial 
progenitor cells responsible for postnatal vasculogenesis in physiological and 
pathological neovascularization. Circ Res 1999;85:221-228.
 26. Shi Q, Rafii S, Wu MH, et  al. Evidence for circulating bone marrow-derived 
endothelial cells. Blood 1998;92:362-367.
 27. Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization 
of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 
1999;5:434-438.
 28. Chen JL, Hunt P, McElvain M, et al. Osteoblast precursor cells are found in CD34+ 
cells from human bone marrow. Stem Cells 1997;15:368-377.
 29. Mifune Y, Matsumoto T, Kawamoto A, et al. Local delivery of granulocyte colony 
stimulating factor-mobilized CD34-positive progenitor cells using bioscaffold for 
modality of unhealing bone fracture. Stem Cells 2008;26:1395-1405.
 30. Schlundt C, El Khassawna T, Serra A, et al. Macrophages in bone fracture healing: 
Their essential role in endochondral ossification. Bone 2015;S8756-3282:00392-0.
Acknowledgement
  this work was carried out at the Analysis Center of life science, Natural science 
Center for Basic Research and Development, Hiroshima university.
Funding statement
  this study was supported by the Highway Program for Realization of Regenerative 
Medicine from the Japan Agency for Medical Research and Development (AMED) 
to M.o.
Author contribution
  K. Mifuji: study inception, Manuscript preparation, and statistical analysis.
  M. Ishikawa: Designed the study, study inception, Manuscript preparation.
  N.Kamei: Assisted in the study process and preparation of the manuscript.
  R. tanaka: Assisted in the design of the study.
  K. Arita: Assisted in the design of the study.
  H. Mizuno: Assisted in the design of the study.
  t. Asahara: Assisted in the design of the study.
  N. Adachi: Assisted in manuscript preparation, Critically reviewed the manuscript.
  M. ochi: Critically reviewed the manuscript.
conflicts of Interest statement
  None declared
© 2017 Mifuji et al. this is an open-access article distributed under the terms of the 
Creative Commons Attributions licence (CC-BY-NC), which permits unrestricted use, 
distribution, and reproduction in any medium, but not for commercial gain, provided 
the original author and source are credited.
